Mentice ABOSTO:MNTC +0.38%76 Gross Margin % is 86.90% as of Mar. 2026, which is 2% above its 10-year median of 84.92. GuruFocus rates OSTO:MNTC with a GF Score™ of 76/100 and a GF Value™ of kr26.00 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Mentice AB ranks better than 96.02% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Mentice AB's Gross Profit for the
three
months ended in Mar. 2026 was kr54.0 Mil. Mentice AB's Revenue for the
three
months ended in Mar. 2026 was kr62.1 Mil. Therefore, Mentice AB's Gross Margin % for the quarter that ended in Mar. 2026 was 86.90%.
The historical rank and industry rank for Mentice AB's Gross Margin % or its related term are showing as below:
OSTO:MNTC'
s Gross Margin % Range Over the Past 10 Years
Min: 75.71 Med: 84.92 Max: 89.89
Current: 88.75
During the past 9 years, the highestGross Margin % of Mentice AB was 89.89%. The lowest was 75.71%. And the median was 84.92%.
OSTO:MNTC's Gross Margin % is ranked better than 96.02% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs OSTO:MNTC: 88.75
Mentice AB had a gross margin of 86.90% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Mentice AB was 3.30% per year.
Mentice AB (OSTO:MNTC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Mentice AB had a gross margin of 86.90% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Mentice AB Gross Margin % Related Terms
Mentice AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Mentice AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MNTC vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Mentice AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mentice AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mentice AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Mentice AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Mentice AB (OSTO:MNTC) has a Gross Margin % of 86.90% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Mentice AB and its competitors. This is near median its historical median of 84.92. Over the past decade, Mentice AB's Gross Margin % has ranged from 75.71 to 89.89. According to the industry distribution chart, Mentice AB ranks #32 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 4%.
Is Mentice AB's Gross Margin % too high?
Mentice AB's current Gross Margin % of 86.90% is near median its 10-year median of 84.92. Over the past 10 years, this metric has ranged from a low of 75.71 to a high of 89.89. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Mentice AB's value of 86.90% is 67% above this industry median. Based on the distribution chart, Mentice AB ranks #32 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Mentice AB has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mentice AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Mentice AB ranks #32 out of 805 companies for Gross Margin %. This places Mentice AB in the top 4% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.03. Mentice AB's value of 86.90% is 67% above this benchmark. Historically, Mentice AB's own Gross Margin % has ranged from 75.71 to 89.89 over the past decade. While the company's 10-year median is 84.92 vs. the industry median of 52.03, Mentice AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mentice AB's current Gross Margin % of 86.90% is 67% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Mentice AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mentice AB's current Gross Margin % is 86.90%, which is near median its own 10-year median of 84.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mentice AB stock overvalued right now?
Based on GuruFocus' analysis, Mentice AB (OSTO:MNTC) is currently considered Possible Value Trap. The stock's GF Value™ is kr26.00, compared to a current price of kr13.05 — trading 49.8% below its estimated fair value. The current Gross Margin % is 86.90%, which is near median its 10-year median of 84.92 and 67% above the Medical Devices & Instruments industry median of 52.03. Mentice AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Mentice AB (OSTO:MNTC), the current Gross Margin % is 86.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mentice AB (OSTO:MNTC) Overvalued in 2026?
Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued.
The current stock price of kr13.05 is trading 49.8% below its estimated GF Value™ of kr26.00.
GuruFocus considers Mentice AB to be Possible Value Trap.
Key valuation signals for OSTO:MNTC:
Gross Margin %: 86.90% (near median its 10-year median of 84.92)
GF Value™: kr26.00 vs. price of kr13.05 (49.8% below fair value)
Industry Position: 67% above the Medical Devices & Instruments median (#32 of 805)
No single metric tells the full story. See the OSTO:MNTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
76GF Score
Get the complete analysis for OSTO:MNTC
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MNTC has been successfully added to your 
